<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1377</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>1998</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>12</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>CYTOKINE AND GROWTH FACTOR MODULATION OF CELL CYCLE EVENTS IN HUMAN MELANOMA CELL LINES</title>
	<subject_fa>General</subject_fa>
	<subject>General</subject>
	<content_type_fa>Original Research: Basic Science in Medicine</content_type_fa>
	<content_type>Original Research: Basic Science in Medicine</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Cytokines influence cell cycle events, which in some but not all instances can
be associated with melanoma progression. Analysis of the G0/G 1 and S phase
fractions of the cell cycle was used to assay the proliferative or inhibitory activity
of cytokines against ten human melanoma cell lines, including pairs of cell lines
derived from primary and metastatic tissue of individual patients. Cytokines and
growth factors were generally capable of inducing either a proliferative or an
inhibitory effect, depending upon the melanoma cell line tested.
Distinct differences in responsiveness between the primary and metastatic
partners of related pairs of melanoma cell lines was observed for IL-l β, IL-6,
TNFα, TGFβ2, IFNα, IFNyand IGF-2. This data is complementary to previous
works1.2 showing IL-6 and TGFβ2 to be inhibitory to.cell lines derived from early,
but not advanced-stage melanomas. These alterations in cell cycle events were
coincidental with a reduced expression of lCAM-1 and/or MHC antigen expression
in response to some of these cytokines.
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Primary and metastatic melanoma, cytokine, cell cycle, proliferative and inhibitory effect, flow cytometry.</keyword>
	<start_page>249</start_page>
	<end_page>257</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-298-454&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>AR</first_name>
	<middle_name></middle_name>
	<last_name>ANDALIB</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004778</code>
	<orcid>20031947532846004778</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>FromEsfahan Medical School, Esfahan,I.R. Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>J</first_name>
	<middle_name></middle_name>
	<last_name>LAWRY</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004779</code>
	<orcid>20031947532846004779</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Sheffield University Medical School, UK</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>BJ</first_name>
	<middle_name></middle_name>
	<last_name>BURNS</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004780</code>
	<orcid>20031947532846004780</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Sheffield University Medical School, UK</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>AK</first_name>
	<middle_name></middle_name>
	<last_name>MURRAY</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004781</code>
	<orcid>20031947532846004781</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Sheffield University Medical School, UK</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>M</first_name>
	<middle_name></middle_name>
	<last_name>HERLYN</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004782</code>
	<orcid>20031947532846004782</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Wistar Institute, Philadelphia, USA.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>RC</first_name>
	<middle_name></middle_name>
	<last_name>REES</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004783</code>
	<orcid>20031947532846004783</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Sheffield University Medical School, UK</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
